GILEAD SCIENCES, INC. — Director's Dealing 2015

Mar 18, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2015-03-16

Reporting Person: BISCHOFBERGER NORBERT W (EVP, R&D and CSO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-03-16	Common Stock	M	20000	$16.395	Acquired	185168	Direct
2015-03-16	Common Stock	M	50000	$20.74	Acquired	235168	Direct
2015-03-16	Common Stock	S	32097	$100.3604	Disposed	203071	Direct
2015-03-16	Common Stock	S	37903	$101.1777	Disposed	165168	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-03-16	Non-Qualified Stock Option (right to buy)	$16.395	M	20000	Disposed	2017-01-22	Common Stock (20000)	Direct
2015-03-16	Non-Qualified Stock Option (right to buy)	$20.74	M	50000	Disposed	2017-05-08	Common Stock (50000)	Direct

Footnotes

F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.

F2: The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.

F3: Sale prices reported for the transactions reported here range from $99.81 to $100.80. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F4: Sale prices reported for the transactions reported here range from $100.81 to $101.57. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request